Spring 2022, May, Volume 2
Antitrust Chronicle® - Healthcare
More than any sector, healthcare has come under particular scrutiny in recent years. The reasons are almost too obvious to state. The pandemic; soaring costs; difficulties in the supply chain for key medicines – all have propelled healthcare to the headlines on both sides of the Atlantic, and beyond.
The vagaries of medical research; the difficulties inherent to insurance; and the intrinsic risks based on investment into medical research all feed into this concern.
